GGrantIndex
← Leaderboards

Timothy E McAlindon

Boston University Medical Campus

$15,710,823
Attributed
$15,710,823
Total exposure
14
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY200520
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$15,710,823 · 14

By mechanism

R01$13,691,368 · 6
T32$677,378 · 1
U01$659,516 · 1
R34$324,447 · 1
P60$197,140 · 2
R55$100,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Boston University Medical Campus

Same institution · by research overlap

Others in their field

Top investigators on “Knee

Research focus

KneeMagnetic Resonance ImagingDegenerative PolyarthritisCartilageMeasurementClinical TrialsSamplingJointsClinical ResearchBone DensityPainBaseParticipantBone MarrowLesionKnee OsteoarthritisBoneScanningBone HealthSeveritiesPhysical FunctionPropertyQuestionnairesStructure

Grant awards (43)

Longterm Effect Of Genicular Nerve Ablation on Knee Pain, Gait and Joint Structure$324,447
R34 · FY2020 · AR · contact PI
Constitutional and metabolic factors associated with the development of Hand OA$425,013
R01 · FY2018 · AR · contact PI
Constitutional and metabolic factors associated with the development of Hand OA$715,139
R01 · FY2017 · AR · contact PI
Constitutional and metabolic factors associated with the development of Hand OA$703,667
R01 · FY2016 · AR · contact PI
Rapid Quantitative Composite MRI Measurement of Knee OA Structural Progression$209,452
U01 · FY2016 · AR · contact PI
Constitutional and metabolic factors associated with the development of Hand OA$770,435
R01 · FY2015 · AR · contact PI
Periarticular Bone Density as a Biomarker for Early Knee OA$454,642
R01 · FY2015 · AR · contact PI
Rapid Quantitative Composite MRI Measurement of Knee OA Structural Progression$223,514
U01 · FY2015 · AR · contact PI
Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT$588,618
R01 · FY2014 · AR · contact PI
Periarticular Bone Density as a Biomarker for Early Knee OA$461,282
R01 · FY2014 · AR · contact PI
Rapid Quantitative Composite MRI Measurement of Knee OA Structural Progression$226,550
U01 · FY2014 · AR · contact PI
Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT$589,395
R01 · FY2013 · AR · contact PI
Periarticular Bone Density as a Biomarker for Early Knee OA$434,423
R01 · FY2013 · AR · contact PI
Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT$758,206
R01 · FY2012 · AR · contact PI
Periarticular Bone Density as a Biomarker for Early Knee OA$459,870
R01 · FY2012 · AR · contact PI
Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT$622,606
R01 · FY2011 · AR · contact PI
The Role of Bone in Osteoarthritis Progression$554,068
R01 · FY2011 · AR · contact PI
Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT$112,079
R01 · FY2011 · AR · contact PI
The Role of Bone in Osteoarthritis Progression$674,043
R01 · FY2010 · AR · contact PI
Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT$673,509
R01 · FY2010 · AR · contact PI
The Role of Bone in Osteoarthritis Progression$620,157
R01 · FY2009 · AR · contact PI
Trial of Vitamin D to Reduce Progression of Knee OA$703,586
R01 · FY2008 · AR · contact PI
The Role of Bone in Osteoarthritis Progression$614,675
R01 · FY2008 · AR · contact PI
The Role of Bone in Osteoarthritis Progression$709,087
R01 · FY2007 · AR · contact PI
Trial of Vitamin D to Reduce Progression of Knee OA$535,189
R01 · FY2007 · AR · contact PI
Trial of Vitamin D to Reduce Progression of Knee OA$495,923
R01 · FY2006 · AR · contact PI
Trial of Vitamin D to Reduce Progression of Knee OA$567,542
R01 · FY2005 · AR
RESEARCH TRAINING IN RHEUMATOLOGY AT NEW ENGLAND MEDICAL$134,240
T32 · FY2005 · AR
RESEARCH TRAINING IN RHEUMATOLOGY AT NEW ENGLAND MEDICAL$185,662
T32 · FY2004 · AR
Trial of Vitamin D to Reduce Progression of Knee OA$100,000
R55 · FY2004 · AR
RESEARCH TRAINING IN RHEUMATOLOGY AT NEW ENGLAND MEDICAL$184,340
T32 · FY2003 · AR
RESEARCH TRAINING IN RHEUMATOLOGY AT NEW ENGLAND MEDICAL$173,136
T32 · FY2002 · AR
CASE CONTROL STUDIES OF RARE DISEASES OVER THE INTERNET$0
P60 · FY2002 · AR
CASE CONTROL STUDIES OF RARE DISEASES OVER THE INTERNET$0
P60 · FY2002 · AR
FEASIBILITY OF INTERNET-BASED TRIALS FOR OSTEOARTHRITIS$200,278
R01 · FY2001 · LM
INVESTIGATE EFFICACY, TOLERABILITY, &SAFETY OF BAY 12 9566$0
M01 · FY2001 · RR
CASE CONTROL STUDIES OF RARE DISEASES OVER THE INTERNET$0
P60 · FY2001 · AR
INDOLE 3 CARBINOL IN THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS$0
M01 · FY2001 · RR
FEASIBILITY OF INTERNET-BASED TRIALS FOR OSTEOARTHRITIS$201,877
R01 · FY2000 · LM
EPIDEMIOLOGIC STUDY OF SLE AMONG AFRICAN AMERICAN WOMEN$197,140
P60 · FY2000 · AR
FEASIBILITY OF INTERNET-BASED TRIALS FOR OSTEOARTHRITIS$46,059
R01 · FY2000 · LM
INVESTIGATE EFFICACY, TOLERABILITY, &SAFETY OF BAY 12 9566$30,487
M01 · FY2000 · RR
INDOLE 3 CARBINOL IN THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS$30,487
M01 · FY2000 · RR